admin

Pakistan’s pharmaceutical sector is shifting from a domestic focus to becoming a high-value global player. At the Pak Pharma & Healthcare Expo 2026, top industry leaders and regulatory experts outlined the roadmap for export expansion: Key Discussion Pillars: Analytical Excellence: Elevating quality control to meet international benchmarks.Digital Integration: Implementing smart compliance systems for global regulatory […]

Good news for the healthcare sector. The Drug Regulatory Authority of Pakistan (DRAP) has officially confirmed that there are no price increases for essential medicines. Despite recent rumors, the supply chain for life-saving drugs is reported as “satisfactory” for the coming months, ensuring both affordability and availability for the general public.

The Drug Regulatory Authority of Pakistan (DRAP) has officially confirmed a three-month stock of essential medicines nationwide. Supported by the Pakistan Pharmaceutical Manufacturers Association (PPMA), the industry remains committed to maintaining a continuous supply of raw materials and ensuring uninterrupted availability for all citizens.

The Pakistan Pharmaceutical Manufacturers Association (PPMA) is proud to announce that Pakistan is exploring the local production of Lenacapavir. This breakthrough, long-acting HIV prevention medicine requires only twice-yearly dosing, offering a revolutionary approach to healthcare and protection.Select 85 more words to run Humanizer.

The Pakistan Pharmaceutical Manufacturers Association (PPMA) is proud to announce a significant milestone in industry diversification. An IPO of Rs 1–2 Billion has been approved for a specialized Veterinary Subsidiary, dedicated to expanding veterinary pharmaceutical manufacturing. This move marks a strategic shift toward internal growth and investment, ensuring that Pakistan’s pharma sector remains a versatile

The PPMA is proud to highlight the growing bilateral trade relationship between Pakistan and Cambodia. As we look toward the Joint Trade Committee meeting, pharmaceuticals remain a top priority for export cooperation and economic growth. Paving the way for global healthcare excellence.

We are pleased to report that more than 80% of missing medicines have been restored to the market. Price deregulation has paved the way for better availability, ensuring that the right treatment is there when you need it most. Together with the PPMA, we’re working toward a healthier, more resilient Pakistan.

The Pakistan Pharmaceutical Manufacturers Association (PPMA) extends its heartfelt congratulations to Prime Minister Mian M. Shehbaz Sharif and Federal Health Minister Syed Mustafa Kamal on the conferment of the first-ever Prime Minister’s Recognition Award upon the Drug Regulatory Authority of Pakistan (DRAP). This award recognizes the landmark regulatory reforms and end-to-end automation that have transformed